Received May 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | MD3414 | — |
COVID-19; COVID-19; This is a spontaneous report received from a Consumer or other non HCP from medical information team. A 67-year-old female patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), on 08Apr2025 as dose 1, single (Lot number: MD3414) for covid-19 immunisation. The patient's relevant medical history included: "type 1 diabetic" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Moderna (DOSE NUMBER UNKNOWN (All of her COVID vaccines prior to Comirnaty were manufactured by Moderna)), for COVID-19 immunization. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset May2025, outcome "unknown" and all described as "COVID-19". It was reported on 20May2025 that the patient contracted COVID-19 the week prior. Therapeutic measures were taken as a result of vaccination failure, covid-19, which included nirmatrelvir, ritonavir (PAXLOVID). No follow-up attempts are possible.
Medical History/Concurrent Conditions: Type 1 diabetes mellitus